Allodynia News and Research

RSS
Allodynia, meaning "other pain", is a painful (noxious) response to a usually non-painful (innocuous) stimulus and can be either static or mechanical. Allodynia differs from referred pain, but can occur in areas other than the one stimulated. It is dysesthetic. Allodynia is different from hyperalgesia, an extreme reaction to a stimulus which is normally painful.
Highly caffeinated alcoholic drinks may induce changes in the adolescent brain similar to cocaine

Highly caffeinated alcoholic drinks may induce changes in the adolescent brain similar to cocaine

Botulinum toxin A injections combat neuropathic pain

Botulinum toxin A injections combat neuropathic pain

Canadian researchers shed light on molecular dynamics of chronic pain

Canadian researchers shed light on molecular dynamics of chronic pain

Researchers identify important neural mechanism responsible for certain chronic pain disorders

Researchers identify important neural mechanism responsible for certain chronic pain disorders

Research shows mustard and garlic receptor is linked to cold-induced pain

Research shows mustard and garlic receptor is linked to cold-induced pain

Molecular mechanisms underlying effects of acupuncture on neuropathic pain

Molecular mechanisms underlying effects of acupuncture on neuropathic pain

Winners of EFIC-Grünenthal-Grant announced

Winners of EFIC-Grünenthal-Grant announced

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Scientists identify molecular mechanism central to development of osteoarthritis pain

Scientists identify molecular mechanism central to development of osteoarthritis pain

Companionship can reduce nerve-related pain

Companionship can reduce nerve-related pain

Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain: an interview with Professor Sally Lawson

Data from MAP Pharmaceuticals’ LEVADEX clinical studies to be presented at AHS meeting

Data from MAP Pharmaceuticals’ LEVADEX clinical studies to be presented at AHS meeting

Single fibronectin injection can prevent chronic pain development after SCI

Single fibronectin injection can prevent chronic pain development after SCI

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy

Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

Diabetes drug rosiglitazone can reduce development of neuropathic pain

Diabetes drug rosiglitazone can reduce development of neuropathic pain

FDA clears Nuvo's IND for Lidocaine Spray formulation

FDA clears Nuvo's IND for Lidocaine Spray formulation

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress